Sort
15,273 grants matching “antimicrobial resistance”
Burkholderia pseudomallei antimicrobial resistance mechanisms
$252,112Herbert P. Schweizer · Colorado State University · U54 · FY2013 · AI
INTERACTION OF ORAL SPIROCHETES WITH GINGIVAL EPITHELIUM
$252,035University Of Washington · R01 · FY2005 · DE
MOLECULAR AND FUNCTIONAL ANALYSES OF THE PMRA/PMRB REGULATORY SYSTEM
$252,000Eduardo A. Groisman · Washington University · R01 · FY2009 · AI
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
$251,916Cleveland Clinic Foundation · R01 · FY2001 · AI
Structural Biology of Gram Positive Virulence Factors
$251,874Cathleen A Earhart · University Of Minnesota · R01 · FY2006 · AI
CD-1 Restricted T-cell Responses in Skin
$251,855Robert L Modlin · University Of California Los Angeles · R01 · FY2009 · AR
Phage-like Chromosomal Islands and Virulence in Pneumococci
$251,600William Michael McShan · Oklahoma State University Stillwater · P20 · FY2018 · GM
Phage-like Chromosomal Islands and Virulence in Pneumococci
$251,600William Michael McShan · Oklahoma State University Stillwater · P20 · FY2019 · GM
Intravascular Port and Disinfection System (PortProtek)
$251,572Patrick Tennican · Hyprotek, Inc. · R43 · FY2020 · AI
Peru Vanderbilt â PREvention through VacciNation Training (PREVENT) program
$251,378Carlos G Grijalva · Vanderbilt University Medical Center · D43 · FY2023 · TW
Vaccine and Treatment Evaluation Units
$251,317Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2015 · AI
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
$251,305Nancy Freitag · University Of Illinois At Chicago · R21 · FY2022 · AI
A Novel High-Throughput Exploration of DNA Supercoiling toward the Therapeutic Manipulation of Bacteria
$251,250Eduardo A. Groisman · Yale University · R21 · FY2023 · AI
Bio-engineered Cell Therapy to Treat Candidiasis
$251,250Pappanaicken Rangasamy Kumaresan · University Of Tx Md Anderson Can Ctr · R21 · FY2024 · AI
Granulysin and the antimicrobial activity of CD8T cells - development of a better model
$251,250Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2022 · AI
Development of nucleic acid-based vaccines against gonorrhea
$251,250Lisa Ann Lewis · Univ Of Massachusetts Med Sch Worcester · R21 · FY2022 · AI
The role of alveolar macrophages during tuberculosis: detrimental or beneficial
$251,250Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · AI
Evaluation of a polypeptide vaccine against Acinetobacter infection
$251,215Bernard Pragash Arulanandam · Tufts University Boston · R21 · FY2024 · AI
Project 1
$251,159Jyotika Sharma · University Of North Dakota · P20 · FY2017 · GM
MECHANISMS OF NITRIC OXIDE CYTOTOXICITY IN SALMONELLOSIS
$250,846University Of Colorado Denver · R01 · FY2000 · AI
The essential role of manganese in persistence of M. tuberculosis under iron starvation.
$250,821Gloria Marcela Rodriguez · Rbhs-New Jersey Medical School · R21 · FY2020 · AI
Radioimmunotherapy of opportunistic infections
$250,625Yeshiva University · R21 · FY2002 · AI
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing
$250,617Christopher R Cox · Cobio Diagnostics Inc. · R43 · FY2020 · DK
Targeting intrinsic resistance to combat multi-drug resistant P. aeruginosa
$250,575Barbara I Kazmierczak · Yale University · R21 · FY2017 · AI
Radioimmunotherapy of opportunistic infections
$250,500Yeshiva University · R21 · FY2003 · AI